News
Guggenheim reaffirmed a "sell" rating on ServiceNow, sticking with a price target of $724, signaling a significant potential ...
Analysts have recently evaluated ServiceNow and provided 12-month price targets. The average target is $1049.14, accompanied ...
ServiceNow, Inc. (NYSE: NOW) is one of the Trending AI Stocks in Focus This Week . On July 16, Cantor Fitzgerald analyst ...
CWM LLC dramatically increased its stake in ServiceNow by 51.2% in Q1, showcasing a bullish view on the tech giant.
There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Interlink Electronics (LINK – Research Report), ServiceNow (NOW – Research Rep ...
Wells Fargo analyst Michael Turrin maintained a Buy rating on ServiceNow yesterday and set a price target of $1,150.00. The company’s shares closed yesterday at $961.78. Elevate ...
"New Relic's consistent recognition as a Leader across all 13 iterations of the Gartner Magic Quadrant for Observability Platforms since 2012 speaks volumes for us. In our view, this report validates ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...
14d
TipRanks on MSNSAIC, ServiceNow partner for Government Risk Reduction Effort offeringScience Applications International Corp. (SAIC) announced a strategic collaboration with ServiceNow (NOW) for a new government risk reduction ...
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Travere Therapeutics's market standing.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc., ServiceNow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results